|
Telomolecular is a regenerative medicine company focused on commercializing its proprietary nano-technologies into large markets with unmet clinical needs and improving patient outcomes.
Telomolecular is actively developing and optimizing pioneering regenerative, curative, and preventative biomedical technologies and therapeutic products to treat and prevent human diseases.
read more
Mission and Objective |
|
In early stage studies conducted at the Cleveland Clinic in 2008, Telomolecular's lead product candidate, nano SOD, demonstrated efficacy in reducing the effects of stroke and reperfusion injury. The company is hoping to begin Phase 1 clinical trials in 2009. Stroke is the 3rd leading cause of death in the United States and a cause of serious, long term disability.
read more
|
|
|
